Results 321 to 330 of about 176,389 (357)
Some of the next articles are maybe not open access.
The effect of ezetimibe on NAFLD
Atherosclerosis Supplements, 2015NAFLD has become the most common liver disorder in countries, where obesity, type 2 diabetes mellitus, dyslipidemia, and metabolic syndrome are common. The strong association between these conditions and the risk of cardiovascular disease make treatment crucial.
openaire +3 more sources
Histological Assessment of NAFLD
Digestive Diseases and Sciences, 2016Nonalcoholic fatty liver disease (NAFLD) covers a spectrum of histological lesions ranging from steatosis to a complex pattern with hepatocyte injury and inflammation in an appropriate clinical context. The disease has been artificially dichotomized into NAFL (steatosis) and NASH (steatosis with hepatocellular injury and inflammation), but it is ...
openaire +2 more sources
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Nature reviews: Gastroenterology & hepatology, 2018Z. Younossi +7 more
semanticscholar +1 more source
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Nature reviews: Gastroenterology & hepatology, 2020J. Aron‐Wisnewsky +7 more
semanticscholar +1 more source
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
Nature reviews: Gastroenterology & hepatology, 2021M. Masoodi +12 more
semanticscholar +1 more source
2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis
Clinical Gastroenterology and Hepatology, 2022Michael Le, Ramsey Cheung, Yuankai Wu
exaly
FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption
Cell Metabolism, 2021Anders Thorell +2 more
exaly
Platelets control liver tumor growth through P2Y12-dependent CD40L release in NAFLD
Cancer Cell, 2022Long-Jun Wu +2 more
exaly